Advertisement
News
Subscribe to Drug Discovery & Development News

The Lead

Nonprescription Diet Pill Alli Back in Stores After Recall

February 27, 2015 | by Associated Press | Comments

The British drugmaker voluntary recalled the product last March after finding some packages in stores didn't contain real alli, indicating tampering after shipment. Read more...              

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Lyric Pharmaceuticals: $20.4M Series A Funding Round

February 27, 2015 1:41 pm | Comments

Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. Read more...                                     

TOPICS:

Panel: Use New Meningitis Vaccines Only For Outbreaks

February 27, 2015 12:58 pm | by Mike Stobbe, AP Medical Writer - Associated Press | Comments

A federal panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students. Read more...

TOPICS:

Takeda's Treatment for Acid-Related Diseases is Now Available in Japan

February 27, 2015 9:10 am | Comments

This medicine treats acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers. Read more...                    

TOPICS:
Advertisement

Novartis's Lung Cancer Drug Recommended for EU Approval

February 27, 2015 9:03 am | Comments

The medication is meant for patients with ALK+ NSCLC previously treated with crizotinib. Read more...                          

TOPICS:

Pancreatic Cancer Subtypes Could Guide Future Treatments

February 27, 2015 8:42 am | by University of Queensland | Comments

Scientists have completed the most comprehensive analysis yet of pancreatic cancer, in a study that could improve future treatments. Read more...                   

TOPICS:

Synthetic Biology Breakthrough Leads to Cheaper Statin Production

February 27, 2015 8:33 am | by University of Manchester | Comments

Researchers have devised a single-step fermentative method for the industrial production of the active drug pravastatin. Read more...                     

TOPICS:

Ebola Doctor: Media, Politicians Fueled the Public's Fear

February 27, 2015 8:29 am | by Tom Mcelroy, Associated Press | Comments

A doctor who contracted the deadly Ebola virus and rode the subway system and dined out before he developed symptoms said the media and politicians could have done a better job by educating people on the science of it. Read more...     

TOPICS:

Sanofi Gets FDA Approval for New Insulin Drug

February 26, 2015 12:06 pm | by Stephanie Guzowski, Editor | Comments

Sanofi announced late Wednesday that it received approval from the U.S. Food and Drug Administration (FDA) to sell its new insulin product Toujeo. The once-daily, long-acting basal insulin will help improve glycemic control in adults with type 1 and type 2 diabetes. Read more..

TOPICS:
Advertisement

New Molecule Could Slow Parkinson's

February 26, 2015 11:55 am | by University of Bath | Comments

In Parkinson’s, a protein called α-synuclein changes shape and stacks with other misshapen proteins. The new molecule binds to the sticky part of α-synuclein, stopping it from clumping and killing brain cells. Read more...

New Understanding of Alzheimer’s

February 26, 2015 11:25 am | by Peter Reuell, Harvard | Comments

Although natural selection is often thought of as a force that determines the adaptation of replicating organisms to their environment, Harvard researchers have found that selection also occurs at the level of neurons, which are post-mitotic cells, and plays a critical role in the emergence of Alzheimer’s disease. Read more...

TOPICS:

Quick Antibiotics Reduce PICU Needs, Mortality of Pediatric Cancer Patients

February 26, 2015 11:18 am | Comments

A University of Colorado Cancer Center study published in the journal Pediatric Blood & Cancer shows that pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and showing neutropenia (low neutrophil count), go on to have decreased intensive care consultation rate and lower mortality compared with patients who receive antibiotics outside the 60-minute window. Read more...

TOPICS:

First Independent U.S. Psoriasis Registry Will Track Drug Safety

February 26, 2015 11:09 am | Comments

People with psoriasis and their health care providers will have the opportunity to participate in research that aims to improve treatments and disease outcomes when the first independent U.S. psoriasis registry begins recruiting patients in 2015. Read more...

TOPICS:

Amgen: Positive Results for CKD Treatment

February 26, 2015 11:05 am | Comments

Amgen announced results from the head-to-head Phase 3 study comparing AMG 416 with cinacalcet for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) receiving hemodialysis. Read more...

TOPICS:

Scientists Develop Method to Suppress Malaria Parasite's Virulence Genes

February 26, 2015 8:41 am | by Hebrew University | Comments

Researchers have revealed the genetic trickery this deadly parasite deploys to escape attack by the human immune system. Read more...                     

TOPICS:

Graphene Shows Potential as Novel Anti-Cancer Therapeutic Strategy

February 26, 2015 8:35 am | by University of Manchester | Comments

Scientists have used graphene to target and neutralize cancer stem cells while not harming other cells. Read more...                         

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading